1.The Association between Platelet/Lymphocyte Ratio and Coronary Artery Disease Severity in Asymptomatic Low Ejection Fraction Patients.
Fatih Mehmet UÇAR ; Burak AÇAR ; Murat GUL ; Ozcan OZEKE ; Sinan AYDOGDU
Korean Circulation Journal 2016;46(6):821-826
BACKGROUND AND OBJECTIVES: Coronary angiography (CAG) is generally needed in the setting of systolic heart failure (HF) with an unidentified etiology as a part of diagnostic strategy. On the other hand, the clinical value of this invasive strategy is largely unknown. Platelet-lymphocyte ratio (PLR) has recently emerged as a novel inflammatory index that may serve as an important predictor of inflammatory state and overall mortality. The present study aimed to search the predictive value of PLR in determining the extent of coronary atherosclerosis in asymptomatic low ejection fraction (EF) patients. SUBJECTS AND METHODS: 156 asymptomatic heart failure (HF) subjects (without angina or HF symptoms, mean age: 58 years; to male: 71.2%) were enrolled, and thereafter a CAG was performed. Gensini Score was used to determine the severity of coronary artery disease (CAD) on CAG. According to this scoring system, the overall study group was categorized into three distinct subgroups: control group with the score 0, mild atherosclerosis group with the score 0 to 20 and severe atherosclerosis group with the score of >20. Thereafter, a comparison was made among groups with regard to mean values of PLR. RESULTS: The severe atherosclerosis group had a substantially higher level of mean PLR in comparison to other groups (p<0.001). Pre-CAG PLR levels as well as a variety of clinical variables including age, low density lipoprotein (LDL)-cholesterol demonstrated an independent correlation with Gensini score through a multivariate analysis. CONCLUSION: These findings suggest the potential association of high PLR levels with severe atherosclerosis in the setting of asymptomatic systolic HF. A simple measurement of PLR helps to identify the severity of coronary atherosclerosis prior to conducting coronary angiography.
Asymptomatic Diseases
;
Atherosclerosis
;
Coronary Angiography
;
Coronary Artery Disease*
;
Coronary Vessels*
;
Hand
;
Heart Failure
;
Heart Failure, Systolic
;
Humans
;
Lipoproteins
;
Male
;
Mortality
;
Multivariate Analysis
2.Serum Irisin Level Can Predict the Severity of Coronary Artery Disease in Patients with Stable Angina.
Tolga Han EFE ; Burak AÇAR ; Ahmet Göktuğ ERTEM ; Kadriye Gayretli YAYLA ; Engin ALGÜL ; Cağrı YAYLA ; Sefa ÜNAL ; Murat BILGIN ; Tolga ÇIMEN ; Ozgür KIRBAŞ ; Ekrem YETER
Korean Circulation Journal 2017;47(1):44-49
BACKGROUND AND OBJECTIVES: The recently discovered myokine irisin has a proposed role in adipose tissue metabolism. The aim of this study was to evaluate the relationship between serum irisin level and the coronary artery severity in patients with stable coronary artery disease (CAD). SUBJECTS AND METHODS: Sixty-three patients who underwent coronary angiography (CA) diagnosed with stable CAD and twenty-six patients with normal coronary artery (NCA) were enrolled in the study. Stable CAD patients were divided into two groups as high synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) score (≥23) and lower SYNTAX score (<23). Serum irisin level measurement was carried out using human irisin colorimetric enzyme-linked immunosorbent assay (ELISA) commercial kit (AG-45A-0046EK-KI01, Adipogen, San Diego, CA, USA) as recommended by the manufacturer's protocol. RESULTS: The patients with stable CAD with a higher SYNTAX score (score ≥23) had significantly lower serum irisin levels (127.91±55.38 ng/mL), as compared the patients with a low SYNTAX score (score <23) (224.69±92.99 ng/mL) and control group (299.54±123.20 ng/mL). Irisin levels showed significant differences between all groups (p<0.001). CONCLUSION: Serum irisin level is an independent predictor of coronary artery severity in patients with stable CAD.
Adipose Tissue
;
Angina, Stable*
;
Atherosclerosis
;
Coronary Angiography
;
Coronary Artery Disease*
;
Coronary Vessels*
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Metabolism
;
Percutaneous Coronary Intervention
;
Taxus
;
Thoracic Surgery